Clinical trial NCT04405453: Contribution of Erector Spina Plane Block to Analgesia for Myofascial Pain Syndrome
Official title: Contribution of Erector Spina Plane Block to Analgesia Combined With Ultrasound Guided Trapezius Muscle Injection for Myofascial Pain Syndrome
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Trigger Point
Myofascial Pain
Keywords: Trigger point , Erector spinae plane block , Ultrasonography
Lead sponsor: Diskapi Teaching and Research Hospital
Sponsor class: OTHER
First posted: 2020-05-28
Enrollment: 60
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: SEQUENTIAL
Intervention model description: Patients with myofasial pain syndrome will randomized into two group. TMI group will receive ultrasound guided trapezius muscle injection two times with one week interval. ESPB group in the 1th week will receive ultrasound guided trapezius muscle injection and in the 2nd week ultrasound guided erector spina plane block will receive. Pain severity of the patients will evaluate by visual analog scale. Datas will obtaine before (week 0) and after (week 1,2,3,4) the injections.
Primary purpose: TREATMENT

Brief summary: Myofascial pain syndrome is a common chronic disease characterized by pain and tenderness in one or more muscle groups. It is characterized by myofascial trigger points that are felt as a band or a nodule harder than normal consistency located in the muscle. Myofascial trigger points are developes as a result of muscle injury ; this can be acute trauma caused by sport injury, accident, or chronic muscle overuse by repetitive occupational activities, emotional stress or poor posture. Trigger point injection is the application of low dose local anesthetic drug into the trigger point.Its main purpose is to weaken the trigger point caused by muscle spasm.However, it may reduce pain partially or have a short duration of action, so it may need to be repeated several times at regular intervals.Trigger point injection can reach trigger points in superficial muscles With the erector spina plane block technique, more effective and long-term pain treatment can be achieved by reaching deeper trigger points. With this hypothesis, we aimed to investigate the contribution of the erector spina plane block to trigger point injection in the treatment of myofascial pain.

Detailed description: Myofascial pain syndrome is a common chronic disease characterized by pain and tenderness in one or more muscle groups. It is characterized by myofascial trigger points that are felt as a band or a nodule harder than normal consistency located in the muscle. Myofascial trigger points are developes as a result of muscle injury ; this can be acute trauma caused by sport injury, accident, or chronic muscle overuse by repetitive occupational activities, emotional stress or poor posture. Trigger point injection is the application of low dose local anesthetic drug into the trigger point.Its main purpose is to weaken the trigger point caused by muscle spasm.However, it may reduce pain partially or have a short duration of action, so it may need to be repeated several times at regular intervals.Trigger point injection can reach trigger points in superficial muscles With the erector spina plane block technique, more effective and long-term pain treatment can be achieved by reaching deeper trigger points. With this hypothesis, we aimed to investigate the contribution of the erector spina plane block to trigger point injection in the treatment of myofascial pain.

Eligibility criteria: Inclusion Criteria:

Clinical diagnosis of Myofascial pain

Exclusion Criteria:

Cervical radiculopathy fibromyalgia

Primary outcomes:
measure: VAS (visual analog scale ) score
timeFrame: before injection (week 0)
measure: VAS (visual analog scale ) score
timeFrame: 1st week after injection
measure: VAS (visual analog scale ) score
timeFrame: 2nd week after injection
measure: VAS (visual analog scale ) score
timeFrame: 3rd week after injection
measure: VAS (visual analog scale ) score
timeFrame: 4th weeks after injection
Secondary outcomes:
Other outcomes:
Locations:
city: Ankara
country: Turkey
facility: Dişkapi Reserch and Education Hospital
Study officials:
affiliation: Diskapi Teaching and Research Hospital
name: damla yürük
role: PRINCIPAL_INVESTIGATOR
affiliation: Diskapi Teaching and Research Hospital
name: ömer taylan akkaya
role: STUDY_DIRECTOR
affiliation: Diskapi Teaching and Research Hospital
name: Hüseyin Alp Alptekin
role: STUDY_CHAIR
References: